Genus Capital Management’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.52M Sell
119,446
-93,370
-44% -$6.53M 0.74% 46
2026
Q1
$16M Sell
212,816
-8,665
-4% -$618K 1.84% 10
2025
Q4
$13.7M Buy
221,481
+56,131
+34% +$3.3M 1.59% 15
2025
Q3
$9.71M Buy
165,350
+122,150
+283% +$7.12M 1.13% 23
2025
Q2
$2.51M Buy
43,200
+14,400
+50% +$814K 0.32% 93
2025
Q1
$1.43M Buy
+28,800
New +$1.47M 0.21% 106

Other funds holding NTR

Genus Capital Management's NTR Position: Q2 2026 in Review

Genus Capital Management reduced its Nutrien (NTR) stake by 44% in Q2 2026, selling an estimated $6.53M and leaving 119,446 shares worth $7.52M. The position accounts for 0.74% of the portfolio, ranked #46.

Genus Capital Management first reported a position in NTR in Q1 2025 and has held it in 6 quarters since. The position peaked at $16M in Q1 2026. 729 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Genus Capital Management held 119,446 shares of Nutrien worth $7.52M as of Q2 2026.
  • Genus Capital Management sold 93,370 Nutrien shares in Q2 2026, an estimated $6.53M.
  • Nutrien made up 0.74% of Genus Capital Management's portfolio in Q2 2026, its #46 holding.
  • Genus Capital Management first reported a position in Nutrien in Q1 2025 and has held it in 6 quarters since.
  • Genus Capital Management's Nutrien position peaked at $16M in Q1 2026.
  • 729 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.